Iran vs Mali: Share of E. coli infections resistant to cephalosporins
Iran
70.6%
in 2022
Mali
60.9%
in 2022
Iran rank
7th
Mali rank
10th
Share of E. coli infections resistant to cephalosporins over time
- Iran
- Mali
How they compare
Iran currently reports 70.6% against 60.9% in Mali, a difference of 9.7%.
That makes Iran's figure about 1.2 times Mali's.
Across all 5 years both countries report, Iran has been ahead every year.
Iran ranks 7th and Mali ranks 10th of 46 countries.
Iran has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Iran | Mali | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 67.9% | 35.9% | 32.0% | Iran |
| 2020s | 70.0% | 56.0% | 14.0% | Iran |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of e. coli infections resistant to cephalosporins, Iran or Mali?
- Iran, at 70.6% against 60.9% in Mali as of 2022.
- What is the difference in share of e. coli infections resistant to cephalosporins between Iran and Mali?
- 9.7%, with Iran ahead.
- How many years of comparable data are there for Iran and Mali?
- 5 years are reported by both, from 2018 to 2022.
- How do Iran and Mali rank globally for share of e. coli infections resistant to cephalosporins?
- Iran ranks 7th and Mali ranks 10th of 46 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of E. coli infections resistant to cephalosporins. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%).